Latest News - Acne

Friday, July 28, 2017 | PracticalDermatology.com, Product Launches and Updates

Cutanea Life Sciences Unveils Facing Forward Mobile App for Acne Patients

Cutanea Life Sciences, Inc. introduced its Facing Forward mobile application for patients who are prescribed Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicate…

Read the full story

Thursday, July 27, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Atopic Derm, Atopic Dermatitis , Eczema, Psoriasis, Valeant NJ

Valeant’s Newly Minted Ortho Dermatologic Unit Makes Big Splash at Summer AAD

It’s go big or go home for the newly re-branded Valeant Ortho Dermatologic division. At the 2017 American Academy of Dermatology in New York City, the company will officially launch …

Read the full story

Monday, July 17, 2017 | Corporate Lawsuits, PracticalDermatology.com, Galderma

Patent Challenge Filed for Generic Version Of Soolantra Cream

Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…

Read the full story

Wednesday, July 12, 2017 | PracticalDermatology.com

Derms Urged to Step Up Role in Antibiotic Stewardship

Dermatologists can and should play a larger role in antibiotic stewardship, according to researchers out of Perelman School of Medicine at the University of Pennsylvania in Philadelphia. Data from …

Read the full story

Thursday, July 06, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

FOREO’s New At-Home Blue Light Acne Pen Hits the US and Canada

FOREO's blue-light acne pen is now available in 333 stores in the US and Canada with more to be added by September 2017. The FOREO ESPADA comprises 415 nanometers (nm) of blue light energy comb…

Read the full story

Wednesday, June 28, 2017 | PracticalDermatology.com, Research and Publications

No Need to Delay Certain Skin Procedures for Isotretinoin Patients

New consensus recommendations set the record straight on the timing of skin procedures for patients taking isotretinoin. After reviewing 32 relevant publications, the authors found “insu…

Read the full story

Friday, June 09, 2017 | PracticalDermatology.com

Murad Adds Two New Blemish-busting Products for Acne Awareness Month

June is acne awareness month, and Murad is rolling out two anti-acne new products to help patients say goodbye to blemishes. The new Pore Extractor Pomegranate Mask ($38 from Murad.com) features vo…

Read the full story

Monday, May 15, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Johnson & Johnson, Neutrogena

CVS Pharmacy's New Long Live Skin Campaign Aims to Increase Awareness of Skin Health

CVS Pharmacy, the retail division of CVS Health, is rolling out a new multi-platform Long Live Skin campaign  to increase awareness about skin health, sun safety and proper skincare. The Long …

Read the full story

Wednesday, May 03, 2017 | PracticalDermatology.com, Research and Publications, BioPharmX Corporation, BioPharmX Corporation

BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for Acne

BioPharmX Corporation’s topical minocycline for acne, BPX-01, achieved its primary endpoint in a phase 2b clinical trial. There were statistically significant reductions in non-nodular inflam…

Read the full story

Monday, May 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

Foamix Announces Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne

Foamix Pharmaceuticals is launching an additional Phase 3 trial for FMX101 in moderate to severe acne, a topical minocycline treatment. If the results are positive, this new Phase 3 trial is expect…

Read the full story

Thursday, April 20, 2017 | PracticalDermatology.com, Product Launches and Updates, BioPharmX Corporation

BioPharmX Completes Phase 2b Trial of BPX-01; Topline Results Coming Soon

BioPharmX Corporation completed their last subject visit in a Phase 2b trial of their investigational acne drug, BPX-01, and the last site close-out visit was April 7, 2017. The company now pl…

Read the full story

Tuesday, April 04, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Novan

Novan Forms New Advisory Council Focused on Nitric Oxide Technologies in Dermatology

Novan, Inc.  has formed an Advisory Council comprised of key opinion leaders with broad expertise in dermatology. These leading physicians will provide medical advice and drug-development insight…

Read the full story

Monday, March 27, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications, Allergan

Allergan and Paratek Pharmaceuticals' Acne Drug Performs Well in Phase 3 Trials

Allergan and Paratek Pharmaceuticals, Inc.’s investigational acne drug performed well in two Phase 3 studies, the companies report. Sarecycline, a once-daily, oral, narrow spectrum tetracycli…

Read the full story

Saturday, March 04, 2017 | PracticalDermatology.com, Product Launches and Updates

Cutanea Unveils Aktipak Gel, 3%/5%, Convenient Acne Treatment for "On-the-Go" Patients

Cutanea Life Sciences, Inc. (CLS) introduced Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicated for the topical treatment of acne vulgaris. The product is availabl…

Read the full story

Friday, February 03, 2017 | Acquisitions and Mergers, PracticalDermatology.com, PracticalDermatology.com, Suneva, ZO Skin Heath

Breaking Business News: ZO Skin Health, Inc. Acquires Refissa from Suneva Medical

ZO Skin Health, Inc. has acquired the worldwide rights to ReFissa as well as its generic equivalent tretinoin from Suneva Medical. Financial terms for the acquisition were not disclosed. ReFissa is…

Read the full story
Load More